Table 1.
Characteristics of Included Patients.
| Post-thrombotic syndrome (n = 45) | |
|---|---|
| Age, years | 54 ± (SD 14) |
| Female | 36 (80.0) |
| BMI * | 25.7 (IQR 5.4) |
| Diabetes | 1 (2.2) |
| PAOD | 0 (0) |
| Smoking * | 17 (40.5) |
| Permanent occlusion | 3 (6.7) |
| Follow-up, years | 6.6 (IQR: 8.0) |
| Stent laterality | |
| Left (unilateral) | 33 (73.3) |
| Right (unilateral) | 3 (6.7) |
| Bilateral | 9 (20.0) |
| Anticoagulant therapy (post-stent) | |
| LMWH switched to VKA | 41 (91.1) |
| LMWH switched to DOAC | 4 (8.9) |
Categorical variables presented as count (%) and continuous variables as mean ± standard deviation (SD) or median with interquartile range (IQR); age and follow-up at time the questionnaire was filled out; PAOD: peripheral arterial occlusive disease; LMWH: low-molecular-weight-heparin; VKA: vitamin-K-antagonist; DOAC: direct-oral anticoagulant; *missing values n = 8 for Body Mass Index (BMI) and n = 3 for smoking.